Delos Wealth Advisors’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
VI
MF
AAM
MAM
WCMNY
Delos Wealth Advisors's XENT Position: Q1 2022 in Review
Delos Wealth Advisors sold out of Intersect ENT, Inc (XENT) in Q1 2022, closing a stake of 22 shares — an estimated $1K sold.
Delos Wealth Advisors first reported a position in XENT in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 131 funds tracked by Wall St. Rank hold XENT as of Q1 2022.
- Delos Wealth Advisors reported no remaining Intersect ENT, Inc position as of Q1 2022 after selling out during the quarter.
- Delos Wealth Advisors sold 22 Intersect ENT, Inc shares in Q1 2022, an estimated $1K.
- Delos Wealth Advisors first reported a position in Intersect ENT, Inc in Q4 2021 and held it in 1 quarter.
- Delos Wealth Advisors's Intersect ENT, Inc position peaked at $1K in Q4 2021.
- 131 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2022.
Based on Delos Wealth Advisors's 13F filing for Q1 2022, filed 16 May 2022.